Arteaus Therapeutics Inks $18M
Arteaus Therapeutics, a company developing drugs to help prevent migraines, has raised $18 million in new venture capital. Atlas Venture and OrbiMed Advisors provided the financing. Jean-Francois Formela, partner at Atlas Venture, and Thomas Schuetz from OrbiMed, serve on the company’s board. Arteaus is based in Cambridge, Mass.
19 October 2011•4 mins read
